
Opinion|Videos|August 1, 2024
Long-term Data with ITB Pumps for Spasticity
Key opinion leaders continue a conversation around ITB pumps in spasticity management.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Efficacy and safety of ITB has been examined in long-term data/trials in multiple sclerosis, cerebral palsy, and stroke?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Overviewing Promising Phase 1/2 Data of Gene Therapy ETX101 in Dravet Syndrome: Joseph Sullivan, MD
2
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
3
Gene Therapy ETX101 Demonstrates Significant Effects on Seizure Reduction, Neurodevelopmental Outcomes in POLARIS Phase 1/2 Program
4
Inside the 2026 MDA Conference: Keynote Insights and Evolving Neuromuscular Care
5



































